Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver

282 indexed citations

Abstract

loading...

About

This paper, published in 2021, received 282 indexed citations. Written by M. Kim, Michaela Jeong, Sun Jin Hur, Y. Cho, Jiyoung Park, Hye Ri Jung, Young-Ho Seo, Ki Taek Nam, K. Lee and Hyukjin Lee covering the research area of Molecular Biology. It is primarily cited by scholars working on Molecular Biology (239 citations), Immunology (51 citations) and Biomaterials (40 citations). Published in Science Advances.

Countries where authors are citing Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver

Specialization
Citations

This map shows the geographic impact of Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver more than expected).

Fields of papers citing Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1126/sciadv.abf4398.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026